Drawing for SANGUINUM

USPTO serial 79036242

SANGUINUM

Reviewed by CopyMark Law Group

Reg. 3445430Status 404
Filing date
Status date
Registration date
Jun 10, 2008
Examiner
CORWIN, CHARLOTTE K
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SANGUINUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003[Cosmetics]SECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment of obesity, weight maintenance, metabolic syndrome, immune system disorders, cancers, cardio-vascular disease, musculoskeletal disorders, osteoporosis, thyroid malfunction, neurogeriatric ailments, environmentally inflicted ailments, menopause, stress, pregnancy related ailments, breastfeeding related ailments, smoking related ailments, dietary related ailments, alcohol related ailments, infectious diseases, rheumatic diseases, allergies, respiratory diseases, skin diseases, pankreatitis, psychological ailments, and pain; and dietetic foods adapted for medical useSECTION 70 - CANCELLED—
035Advertising; business management; business administration; office functionsSECTION 70 - CANCELLED—
044Medical services; hygienic and beauty care for human beings in the nature of medical cosmetic bodycare services; and healthcare services, namely, wellness programsSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 7, 2018DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 6, 2018DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 10, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Dec 22, 2016CHLDCHANGE OF OWNER RECEIVED FROM IB—
Aug 18, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 19, 2015CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jul 3, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jun 12, 2015INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 12, 2015INPCINVALIDATION PROCESSED—
Jan 17, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 18, 2014ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 25, 2014TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 17, 2014NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
May 17, 2014C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
May 17, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 12, 2014715FREGISTERED - SEC. 71 & SEC. 15 FILED—
May 12, 2014ES75TEAS SECTION 71 & 15 RECEIVED—
Jul 18, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 1, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 30, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 26, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 26, 2008FIMPFINAL DISPOSITION PROCESSED—
Sep 10, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 10, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 25, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 5, 2008NPUBNOTICE OF PUBLICATION—
Feb 21, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 21, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 20, 2008CNEAEXAMINERS AMENDMENT MAILED—
Feb 20, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Feb 20, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 11, 2008DOCKASSIGNED TO EXAMINER—
Jan 31, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 31, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 31, 2008ALIEASSIGNED TO LIE—
Dec 19, 2007MAILPAPER RECEIVED—
Nov 14, 2007ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2007REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 19, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 1, 2007CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 1, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2007RFNTREFUSAL PROCESSED BY IB—
May 3, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 3, 2007RFRRREFUSAL PROCESSED BY MPU—
May 1, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Apr 30, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2007DOCKASSIGNED TO EXAMINER—
Apr 27, 2007NWAPNEW APPLICATION ENTERED—
Apr 26, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance